Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only
- PMID: 31112429
- DOI: 10.1080/00952990.2019.1607363
Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only
Abstract
Background: While there is growing interest in the possibility that cannabis may be a partial substitute for opioids, studies have yet to examine whether individuals with co-occurring opioid and cannabis use disorders (OUD and CUD) have less risk of negative outcomes than those with OUD only. Objective: This study sought to compare the sociodemographic and clinical characteristics of patients diagnosed with co-occurring OUD and CUD to patients with OUD only, CUD only, and patients with any other drug use disorders. We hypothesized that co-occurring OUD and CUD would be associated with lower risk of inpatient admissions and emergency department (ED) visits, lower rates of homelessness, and fewer opioid prescriptions. Methods: Comparisons were based on bivariate analyses, logistic and linear multiple regression models of National Veterans Health Administration (VHA) data from Fiscal Year 2012. Results: Of the 234,181 (94% male) patients diagnosed with drug use disorders, 8.6% were diagnosed with co-occurring OUD and CUD; 33.3% with OUD only; 26.5% with CUD only; and 31.6% with other drug use disorders. Compared to the OUD only group (Mean = 4.8 (SD = 8.84)), the group with co-occurring OUD and CUD was associated with a lower number of opioid prescriptions (Mean = 3.79 (SD = 8.22)) (d = -0.16), but higher likelihood of inpatient psychiatric admission (RR = 1.95) and homelessness (RR = 1.52), and no significant difference in ED visits. Conclusions: These data highlight the need to further investigate whether the complex effects of cannabis use on patients with OUD are counterbalanced by potential benefits of reduced in opioid prescribing.
Keywords: Cannabis; addiction; cannabis use disorder; comorbidity; opioid crisis; opioid use disorder; opioids; substance use disorders.
Similar articles
-
Brief report: Cannabis and opioid use disorder among heart failure admissions, 2008-2018.PLoS One. 2021 Sep 30;16(9):e0255514. doi: 10.1371/journal.pone.0255514. eCollection 2021. PLoS One. 2021. PMID: 34591847 Free PMC article.
-
Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults.Exp Clin Psychopharmacol. 2023 Dec;31(6):998-1004. doi: 10.1037/pha0000649. Epub 2023 May 11. Exp Clin Psychopharmacol. 2023. PMID: 37166911
-
The association of opioid use disorder and homelessness nationally in the veterans health administration.Drug Alcohol Depend. 2021 Jun 1;223:108714. doi: 10.1016/j.drugalcdep.2021.108714. Epub 2021 Apr 14. Drug Alcohol Depend. 2021. PMID: 33865213
-
The phenomics and genetics of addictive and affective comorbidity in opioid use disorder.Drug Alcohol Depend. 2021 Apr 1;221:108602. doi: 10.1016/j.drugalcdep.2021.108602. Epub 2021 Feb 22. Drug Alcohol Depend. 2021. PMID: 33652377 Free PMC article. Review.
-
Prevalence and impact of cannabis use disorder on acute ischemic stroke and subsequent mortality in elderly peripheral vascular disease patients: A population-based analysis in the USA (2016 - 2019).Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102162. doi: 10.1016/j.cpcardiol.2023.102162. Epub 2023 Oct 21. Curr Probl Cardiol. 2024. PMID: 37871709 Review.
Cited by
-
Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain.Drug Alcohol Rev. 2025 Mar;44(3):799-810. doi: 10.1111/dar.14014. Epub 2025 Feb 26. Drug Alcohol Rev. 2025. PMID: 40011075
-
Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis.Int J Drug Policy. 2023 Sep;119:104113. doi: 10.1016/j.drugpo.2023.104113. Epub 2023 Jul 21. Int J Drug Policy. 2023. PMID: 37481875 Free PMC article.
-
Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review.J Clin Med. 2020 Dec 23;10(1):15. doi: 10.3390/jcm10010015. J Clin Med. 2020. PMID: 33374666 Free PMC article. Review.
-
Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.Addict Biol. 2023 Sep;28(9):e13317. doi: 10.1111/adb.13317. Addict Biol. 2023. PMID: 37644897 Free PMC article. Clinical Trial.
-
Sex differences in Cannabis use disorder and associated psychosocial problems among US adults, 2012-2013.Prev Med. 2023 Mar;168:107422. doi: 10.1016/j.ypmed.2023.107422. Epub 2023 Jan 11. Prev Med. 2023. PMID: 36641126 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical